Table 3 Summary of discordant results between different tests
From: Comparing the performance of six human papillomavirus tests in a screening population
BD HPV | Roche Cobas | Qiagen Hybrid Capture 2 | Abbott RealTi m e High Risk HPV | Gen-Probe APTIMA | NorChip PreTect HPV-Proofer | |
|---|---|---|---|---|---|---|
BD HPV | — | 0.83 | 0.78 | 0.81 | 0.65 | 0.33 |
Roche Cobas | (145, 134)a | — | 0.75 | 0.85 | 0.64 | 0.35 |
1.1 (0.8, 1.4) | ||||||
Qiagen Hybrid Capture 2 | (204, 141) | (225, 174) | — | 0.78 | 0.68 | 0.35 |
1.4 (1.2, 1.8) | 1.3 (1.1, 1.6) | |||||
Abbott RealTime High Risk HPV | (227, 57) | (194, 35) | (216, 108) | — | 0.70 | 0.39 |
4.0 (3.0, 5.4) | 5.5 (3.9, 8.2) | 2.0 (1.6, 2.5) | ||||
Gen-Probe APTIMA | (421, 70) | (414, 77) | (353, 68) | (279, 97) | — | 0.45 |
6.0 (4.7, 7.9) | 5.4 (4.2, 6.9) | 5.2 (4.0, 6.8) | 2.9 (2.3, 3.7) | |||
NorChip PreTect HPV-Proofer | (684, 61) | (670, 54) | (625, 63) | (532, 65) | (375, 82) | — |
11.2 (8.6, 14.8) | 12.4 (9.4, 16.7) | 9.9 (7.6, 13.1) | 8.2 (6.3, 10.8) | 4.6 (3.6, 5.9) |
